Marzetti Q1 sales slightly miss, profit falls on cyclospora outbreak, higher costs

By Reuters News


Overview

  • U.S. specialty food maker's fiscal Q1 sales declined 2.4%, slightly missing analyst expectations

  • Adjusted EPS for fiscal Q1 fell and missed analyst expectations

  • Company says cyclospora outbreak and higher costs drove declines in sales and profit


Outlook

  • Company expects Retail segment sales to benefit from Bachan’s acquisition and new product launches

  • Company anticipates Foodservice sales to remain supported by select quick-service restaurant customers

  • Company expects moderate commodity cost inflation and higher diesel and freight costs, to be mitigated by pricing and cost savings


Result Drivers

  • CYCLOSPORA OUTBREAK - Co said cyclospora outbreak reduced demand and sales for both Retail and Foodservice segments, with estimated 4% decline in Retail and 2% in Foodservice

  • HIGHER COSTS - Co said significantly higher diesel and freight costs and commissioning costs for new production capacity reduced gross profit and operating income

  • BACHAN’S ACQUISITION - Newly acquired Bachan’s brand contributed $17.8 mln in incremental Retail segment sales, offsetting some sales decline


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Slight Miss*

$481.52 mln

$484 mln (5 Analysts)

Q1 Adjusted EPS

Miss

$1.14

$1.36 (4 Analysts)

Q1 Net Income

$29.30 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the food processing peer group is "buy."

  • Wall Street's median 12-month price target for The Marzetti Company is $135.00, about 21.7% above its November 2 closing price of $110.93

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Nov 3 - Taco Bell sales fall more than expected on cyclosporiasis outbreak hit

  • Nov 3 - Yum Brands tops Q3 adjusted EPS estimates

  • Nov 3 - Keurig Dr Pepper beats quarterly estimates on steady demand for pricier drinks


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.